Targeting CD137 enhances the efficacy of cetuximab

Por Kohrt, Holbrook E., Colevas, A. Dimitrios, Houot, Roch, Weiskopf, Kipp, Goldstein, Matthew J., Lund, Peder, Mueller, Antonia, Sagiv-Barfi, Idit, Marabelle, Aurelien, Lira, Ruth, Troutner, Emily, Richards, Lori, Rajapaska, Amanda, Hebb, Jonathan, Chester, Cariad, Waller, Erin, Ostashko, Anton, Weng, Wen-Kai, Chen, Lieping, Czerwinski, Debra, Fu, Yang-Xin, Sunwoo, John, Levy, Ronald
Publicado em 2014

Targeting CD137 enhances the efficacy of cetuximab

Por Kohrt, Holbrook E., Colevas, A. Dimitrios, Houot, Roch, Weiskopf, Kipp, Goldstein, Matthew J., Lund, Peder, Mueller, Antonia, Sagiv-Barfi, Idit, Marabelle, Aurelien, Lira, Ruth, Troutner, Emily, Richards, Lori, Rajapaska, Amanda, Hebb, Jonathan, Chester, Cariad, Waller, Erin, Ostashko, Anton, Weng, Wen-Kai, Chen, Lieping, Czerwinski, Debra, Fu, Yang-Xin, Sunwoo, John, Levy, Ronald
Publicado no J Clin Invest (2019)